Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Insight Public Affairs

We are an award winning 15-strong team of consultants able to offer extensive experience in politics, government, media and stakeholder engagement, across a breadth of policy areas including telecoms, technology, gambling, life sciences, financial services, housing, infrastructure, copyright, employment, media and advertising, food and drink, social care, retail, and education. As an independent agency we go that extra mile to deliver results-focussed communications strategies and programmes that fulfil our clients’ commercial imperatives. Working tirelessly to meet our clients’ goals, we are a team who understand client challenges, develop bespoke strategies and programmes, and meet these strategic objectives.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Health policy and government affairs, Market access, Market research

Company Details

Insight Public Affairs
52 Grosvenor Gardens, London, SW1W 0AU, United Kingdom
+44 (0)20 7824 1865
Contact Insight Public Affairs
Website

 Latest Content from PMHub 

Givers and Takers

White Papers and Resources | January 10, 2019 | Page & Page Health

Have we lost the ability to identify the difference between net givers and net takers of energy?

Joint working that works

Videos and Podcasts | January 8, 2019 | Dovetail

Q&A with Dr Timothy Vollmer, leading MS Neurologist

White Papers and Resources | January 8, 2019 | Blue Latitude Health

Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face...

Living my best life with multiple sclerosis

White Papers and Resources | January 7, 2019 | Blue Latitude Health

Multi-award-winning advocate and patient engagement champion Trishna Bharadia gives a valuable insight into life with multiple sclerosis. She explains how treatment has changed, how our healthcare systems and pharma can...

A well-deserved promotion within Porterhouse Medical’s scientific services team

Press Releases | January 7, 2019 | Porterhouse Medical Group

Porterhouse Medical is delighted to announce the promotion of Amanda Hyne to senior medical writer within our scientific services team.2018 has been a tremendous year for Amanda. She has made...

Creative review: ESMO 2018

White Papers and Resources | January 4, 2019 | Blue Latitude Health

BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners and giving key insights on how to develop an...

Focus on doing one thing well

White Papers and Resources | January 4, 2019 | Page & Page Health

Does pharma have something to learn from Welsh jeans maker Hiut Denim when it comes to focus?

A unique tool for turning data into brand strategy

White Papers and Resources | January 3, 2019 | Blue Latitude Health

Head of Insight Martine Leroy, uses her 25+ years’ experience to develop an exclusive perceptual framework for research design and analysis, which generates a deeper understanding of customer needs and...

Positive disruption: getting to the bottom of big data

White Papers and Resources | January 2, 2019 | Blue Latitude Health

BLH speaks to Nicole Huyghe, founder and Managing Director of data science consultancy Boobook, about the growing need from businesses for data-driven decision making.

Highlights in haematologic malignancy from ASH 2018

White Papers and Resources | December 20, 2018 | Porterhouse Medical Group

The ASH congress is the most comprehensive haematology event of the year, over 5000 abstracts covering new developments in malignant and non-malignant haematology were presented. Here we focus on two...